Carbapenemases: the Versatile Beta-lactamases

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 2007 Jul 17

PMID 17630334

Citations 991

Authors

Anne Marie Queenan

Karen Bush

Affiliations

Soon will be listed here.

Abstract

Carbapenemases are beta-lactamases with versatile hydrolytic capacities. They have the ability to hydrolyze penicillins, cephalosporins, monobactams, and carbapenems. Bacteria producing these beta-lactamases may cause serious infections in which the carbapenemase activity renders many beta-lactams ineffective. Carbapenemases are members of the molecular class A, B, and D beta-lactamases. Class A and D enzymes have a serine-based hydrolytic mechanism, while class B enzymes are metallo-beta-lactamases that contain zinc in the active site. The class A carbapenemase group includes members of the SME, IMI, NMC, GES, and KPC families. Of these, the KPC carbapenemases are the most prevalent, found mostly on plasmids in Klebsiella pneumoniae. The class D carbapenemases consist of OXA-type beta-lactamases frequently detected in Acinetobacter baumannii. The metallo-beta-lactamases belong to the IMP, VIM, SPM, GIM, and SIM families and have been detected primarily in Pseudomonas aeruginosa; however, there are increasing numbers of reports worldwide of this group of beta-lactamases in the Enterobacteriaceae. This review updates the characteristics, epidemiology, and detection of the carbapenemases found in pathogenic bacteria.

Citing Articles

Virulence factors, molecular characteristics, and resistance mechanisms of carbapenem-resistant Pseudomonas aeruginosa isolated from pediatric patients in Shanghai, China.

Yin L, Bao Z, He L, Lu L, Lu G, Zhai X BMC Microbiol. 2025; 25(1):130.

PMID: 40069638 PMC: 11895140. DOI: 10.1186/s12866-025-03856-1.

Molecular epidemiology of Escherichia coli in bloodstream infections from a general hospital in Ningxia, China, 2022-2023.

Hu X, Tao J, Yan L, Hong W, Wang W, Wang L BMC Infect Dis. 2025; 25(1):293.

PMID: 40021996 PMC: 11871600. DOI: 10.1186/s12879-025-10658-3.

Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health.

Alvisi G, Curtoni A, Fonnesu R, Piazza A, Signoretto C, Piccinini G Antibiotics (Basel). 2025; 14(2).

PMID: 40001385 PMC: 11852015. DOI: 10.3390/antibiotics14020141.

Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and other WHO priority pathogens, including Candida auris.

Mishra S, Yasir M, Kuppusamy R, Wong E, Hui A, Sorensen K J Appl Microbiol. 2025; 136(3).

PMID: 39933590 PMC: 11879280. DOI: 10.1093/jambio/lxaf031.

Systematic review of multidrug-resistant in the Arabian Peninsula: molecular epidemiology and resistance patterns.

Idrees E, Aldriwesh M, Alkhulaifi M, Alghoribi M Front Microbiol. 2025; 16:1489317.

PMID: 39927260 PMC: 11802542. DOI: 10.3389/fmicb.2025.1489317.

References

Turner P . Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997-2002). Diagn Microbiol Infect Dis. 2005; 51(4):281-9. DOI: 10.1016/j.diagmicrobio.2004.11.013. View

Pitout J, Chow B, Gregson D, Laupland K, Elsayed S, Church D . Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J Clin Microbiol. 2006; 45(2):294-8. PMC: 1829051. DOI: 10.1128/JCM.01694-06. View

Yan J, Ko W, Wu J . Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001; 45(8):2368-71. PMC: 90656. DOI: 10.1128/AAC.45.8.2368-2371.2001. View

Nicolas-Chanoine M, Labia R . A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins. FEMS Microbiol Lett. 1996; 143(1):29-33. DOI: 10.1111/j.1574-6968.1996.tb08457.x. View

Tortola M, Lavilla S, Miro E, Gonzalez J, Larrosa N, Sabate M . First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother. 2005; 49(8):3492-4. PMC: 1196258. DOI: 10.1128/AAC.49.8.3492-3494.2005. View

Peleg A, Franklin C, Bell J, Spelman D . Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from Australia. J Antimicrob Chemother. 2004; 54(3):699-700. DOI: 10.1093/jac/dkh398. View

Poirel L, Weldhagen G, Naas T, De Champs C, Dove M, Nordmann P . GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother. 2001; 45(9):2598-603. PMC: 90698. DOI: 10.1128/AAC.45.9.2598-2603.2001. View

Medeiros A . Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis. 1997; 24 Suppl 1:S19-45. DOI: 10.1093/clinids/24.supplement_1.s19. View

Shannon K, King A, Phillips I . Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother. 1986; 17(1):45-50. DOI: 10.1093/jac/17.1.45. View

10.

Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B . Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother. 2005; 49(7):3018-20. PMC: 1168646. DOI: 10.1128/AAC.49.7.3018-3020.2005. View

11.

Yong D, Choi Y, Roh K, Kim C, Park Y, Yum J . Increasing prevalence and diversity of metallo-beta-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. Antimicrob Agents Chemother. 2006; 50(5):1884-6. PMC: 1472216. DOI: 10.1128/AAC.50.5.1884-1886.2006. View

12.

Sougakoff W, Naas T, Nordmann P, Collatz E, Jarlier V . Role of ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A beta-lactamase Sme-1. Biochim Biophys Acta. 1999; 1433(1-2):153-8. DOI: 10.1016/s0167-4838(99)00138-7. View

13.

Poirel L, Heritier C, Nordmann P . Genetic and biochemical characterization of the chromosome-encoded class B beta-lactamases from Shewanella livingstonensis (SLB-1) and Shewanella frigidimarina (SFB-1). J Antimicrob Chemother. 2005; 55(5):680-5. DOI: 10.1093/jac/dki065. View

14.

Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

15.

Lee K, Yum J, Yong D, Lee H, Kim H, Docquier J . Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005; 49(11):4485-91. PMC: 1280121. DOI: 10.1128/AAC.49.11.4485-4491.2005. View

16.

Materon I, Queenan A, Koehler T, Bush K, Palzkill T . Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob Agents Chemother. 2003; 47(6):2040-2. PMC: 155864. DOI: 10.1128/AAC.47.6.2040-2042.2003. View

17.

Tenover F, Kalsi R, Williams P, Carey R, Stocker S, Lonsway D . Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis. 2006; 12(8):1209-13. PMC: 3291231. DOI: 10.3201/eid1208.060291. View

18.

Coelho J, Turton J, Kaufmann M, Glover J, Woodford N, Warner M . Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol. 2006; 44(10):3623-7. PMC: 1594798. DOI: 10.1128/JCM.00699-06. View

19.

Naas T, Vandel L, Sougakoff W, Livermore D, Nordmann P . Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob Agents Chemother. 1994; 38(6):1262-70. PMC: 188196. DOI: 10.1128/AAC.38.6.1262. View

20.

Marra A, Pereira C, Gales A, Menezes L, Cal R, de Souza J . Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother. 2005; 50(1):388-90. PMC: 1346770. DOI: 10.1128/AAC.50.1.388-390.2006. View